A Rofecoxib‐Derived Theranostic Probe and Its Combination With PD‐1 Inhibitor for High‐Efficiency Cancer Therapy
Year: 2025
Type: article
Language: en
Topic: Inflammatory mediators and NSAID effects
Authors and affiliations:
raw_author_name: Xinli Wang
raw_affiliation_strings: Department of Medical Oncology Fujian Medical University Union Hospital Fuzhou Fujian People's Republic of China
Fujian Provincial Key Laboratory of Screening for Novel Microbial Products Fujian Institute of Microbiology Fuzhou Fujian People's Republic of China
Department of Medical Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian, People's Republic of China
raw_author_name: Xia Wang
raw_affiliation_strings: Department of Medical Oncology Fujian Medical University Union Hospital Fuzhou Fujian People's Republic of China
Fujian Provincial Key Laboratory of Screening for Novel Microbial Products Fujian Institute of Microbiology Fuzhou Fujian People's Republic of China
Fujian Provincial Key Laboratory of Screening for Novel Microbial Products, Fujian Institute of Microbiology, Fuzhou, Fujian, People's Republic of China
raw_author_name: Xuejing Su
raw_affiliation_strings: College of Life Sciences Fujian Agriculture and Forestry University Fuzhou Fujian People's Republic of China
Fujian Provincial Key Laboratory of Screening for Novel Microbial Products Fujian Institute of Microbiology Fuzhou Fujian People's Republic of China
College of Life Sciences, Fujian Agriculture and Forestry University, Fuzhou, Fujian, People's Republic of China
Fujian Provincial Key Laboratory of Screening for Novel Microbial Products, Fujian Institute of Microbiology, Fuzhou, Fujian, People's Republic of China
raw_author_name: Zexin Wang
raw_affiliation_strings: Fujian Provincial Key Laboratory of Screening for Novel Microbial Products Fujian Institute of Microbiology Fuzhou Fujian People's Republic of China
Fujian Provincial Key Laboratory of Screening for Novel Microbial Products, Fujian Institute of Microbiology, Fuzhou, Fujian, People's Republic of China
raw_author_name: Yongxiao Sun
raw_affiliation_strings: Fujian Provincial Key Laboratory of Screening for Novel Microbial Products Fujian Institute of Microbiology Fuzhou Fujian People's Republic of China
Fujian Provincial Key Laboratory of Screening for Novel Microbial Products, Fujian Institute of Microbiology, Fuzhou, Fujian, People's Republic of China
raw_author_name: Lijun Xie
raw_affiliation_strings: College of Life Sciences Fujian Agriculture and Forestry University Fuzhou Fujian People's Republic of China
Fujian Provincial Key Laboratory of Screening for Novel Microbial Products Fujian Institute of Microbiology Fuzhou Fujian People's Republic of China
Fujian Provincial Key Laboratory of Screening for Novel Microbial Products, Fujian Institute of Microbiology, Fuzhou, Fujian, People's Republic of China
College of Life Sciences, Fujian Agriculture and Forestry University, Fuzhou, Fujian, People's Republic of China
raw_author_name: Xiaoyan Lin
raw_affiliation_strings: Department of Medical Oncology Fujian Medical University Union Hospital Fuzhou Fujian People's Republic of China
Department of Medical Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian, People's Republic of China